Georgiamune and Menarini Group Enter Exclusive Global License and Collaboration Agreement for GIM-621 October 28, 2026
Zymeworks Enters into an Exclusive Global License and Collaboration Agreement with Roche for ZW209 October 28, 2026
Akeso Announces Summit Therapeutics and ECOG-ACRIN Cancer Research Group Enter into Ph 2/3 Clinical Trial Collaboration to Evaluate Ivonescimab in 1L BTC October 27, 2026
Vir Biotechnology and Gilead Sciences to Discover and Develop Novel PRO-XTEN® Dual-masked T-cell Engagers for Solid Tumors October 20, 2026
Marker Therapeutics Awarded $2.6 Million FDA Orphan Products Development Grant to Advance MT-601 in Pancreatic Cancer October 20, 2026
Hansoh Pharma Announces Strategic Collaboration and License Agreement With Roche to Advance Novel ADC Portfolio October 20, 2026
Alentis and PinotBio announce collaboration to develop next-generation ADCs targeting claudin-1 October 20, 2026
Adlai Nortye Enters Clinical Collaboration with Lilly and Merck KGaA to Evaluate Combination of AN4035 and Cetuximab October 20, 2026
NUCLIDIUM and NorthStar Enter Long-term Strategic Partnership to Advance NUCLIDIUM’s Copper-67 Radiotheranostic Oncology Pipeline October 20, 2026
KymaThera Announces $80 Million Series B Financing to Advance K-1728, a Next-Gen Pan-Mutant Selective PI3Kα Inhibitor October 14, 2026
Prelude and Lilly to Evaluate PRT13722 in Combination with Verzenio® and Inluriyo® in Patients with HR+/HER2- Breast Cancer October 14, 2026
Genezen and InterAct Therapeutics Partner to Advance AAV8-based Gene Therapy for Liver-Dominant Metastatic Breast Cancer October 14, 2026
SRX Global to Acquire CERo Therapeutics, a Company Developing CER 1236 for Hematologic Malignancies October 14, 2026
Tempus Announces Multi-Year Collaboration with Moderna and Merck, to Support Potential Commercialization of Intismeran Autogene October 14, 2026
Ligand and AvenCell Therapeutics Enter Financing Agreement to Advance Pipeline of Next-Generation CAR-T Therapies for Up to $47 Million October 6, 2026
AstraZeneca, Daiichi Sankyo, and Summit Therapeutics to evaluate Datroway + ivonescimab combo across multiple tumour types October 6, 2026
Nurix Therapeutics Announces Second Research Term Extension for Oncology Program Under Collaboration with Gilead Sciences October 6, 2026
United Immunity Announces Master Clinical Supply Agreement with Roche to Evaluate UI-102 + Anti–PD-L1 Therapy in Advanced Solid Tumors October 6, 2026
Legend Biotech Launches Inaugural ELITE Grant Program to Advance the Next Generation of CAR-T Innovation in Multiple Myeloma October 6, 2026
Abogen Announces Licensing and Option Agreement with Novartis to Advance mRNA-Encoded T-Cell Engager and other potential RNA programs October 6, 2026
Earendil Labs Announces Research Collaboration with Genentech to Discover and Develop Therapeutic Bispecific Antibodies in Oncology October 1, 2026
